Aurinia Pharmaceuticals Inc.
AUPH· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- –
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +41.4%
We record prices for the companies we cover; AUPH is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 138.7M
- Revenue
- $283.1M
- Free cash flow
- –
- Owner earnings
- –
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- 37.1%
- Net
- 101.5%
- Free cash flow
- –
- Owner earnings
- –
- Stock pay
- 5.2%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- 49.4%
- ROE, 5 yr avg
- -6.8%
Growth (CAGR)
- Revenue, 3 yr
- 28.3%
- Revenue, 5 yr
- 41.4%
- Revenue, 7 yr
- 150.1%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Diluted EPS, 7 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
- Free cash flow, 7 yr
- –
Financial health · FY2025
- Cash and investments
- $80.2M
- Total debt
- –
- Net cash
- –
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- 3.2%
Financials: ten years from the 10-Ks
Revenue
$283.1M
+150.1% a year over 7 years
FY2018FY2025
Margins
Operating37.1%Net101.5%
FY2025
FY2018FY2025
Diluted shares
138.7M
+17.1% over 7 years, net dilution
FY2018FY2025
Every figure, year by year
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| The business | ||||||||
| Revenue | $463.0K | $318.0K | $50.1M | $45.6M | $134.0M | $175.5M | $235.1M | $283.1M |
| Revenue growth | – | -31.3% | 15660.4% | -9.0% | 193.9% | 31.0% | 34.0% | 20.4% |
| Gross margin | – | – | – | – | – | – | – | – |
| Operating margin | -11930.9% | -28598.4% | -208.1% | -396.3% | -83.2% | -52.2% | -2.0% | 37.1% |
| Net income | -$53.1M | -$88.4M | -$102.7M | -$181.0M | -$108.2M | -$78.0M | $5.8M | $287.2M |
| Net margin | -11464.1% | -27794.0% | -204.9% | -396.8% | -80.7% | -44.5% | 2.4% | 101.5% |
| Diluted EPS | – | $-0.95 | $-0.87 | $-1.40 | $-0.76 | $-0.54 | $0.04 | $2.07 |
| Return on invested capital? | – | – | – | – | – | – | – | – |
| Cash | ||||||||
| Operating cash flow | -$51.6M | -$63.6M | -$69.9M | -$157.7M | -$79.5M | -$33.5M | $44.4M | $135.7M |
| Capital expenditure | – | – | – | – | – | – | – | – |
| Free cash flow | – | – | – | – | – | – | – | – |
| Stock-based compensation | $6.9M | $7.4M | $17.5M | $31.2M | $32.3M | $45.3M | $31.6M | $14.7M |
| Owner earnings? | – | – | – | – | – | – | – | – |
| Free cash flow per share | – | – | – | – | – | – | – | – |
| Capital allocation | ||||||||
| Dividends paid | – | – | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | $0 | $0 | $40.2M | $98.2M |
| Diluted shares | – | – | 118.5M | 129.4M | 141.9M | 143.2M | 146.2M | 138.7M |
| Share count change? | – | – | – | 9.2% | 9.7% | 0.9% | 2.1% | -5.1% |
| Balance sheet | ||||||||
| Cash and equivalents | $118.0M | $306.0M | $272.4M | $231.6M | $94.1M | $48.8M | $83.4M | $80.2M |
| Short-term investments | – | – | – | – | – | – | – | – |
| Total debt | – | – | – | – | – | – | – | – |
| Net debt | – | – | – | – | – | – | – | – |
| Shareholders' equity | $135.7M | $298.6M | $407.8M | $479.1M | $405.4M | $378.0M | $377.5M | $581.3M |
Latest filings
| 2026-10-30 | 10-Q | Quarterly report |
| 2026-10-30 | 8-K | Earnings release |
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Earnings release |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-05-07 | 8-K | Earnings release |
| 2026-04-21 | DEF 14A | Proxy statement |
| 2026-02-26 | 10-K | Annual report |
| 2026-02-26 | 8-K | Earnings release |
| 2025-11-04 | 8-K | Earnings release |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
